- $1.75bn
- $1.65bn
- $6.50m
Annual balance sheet for Anterix, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 106 | 43.2 | 60.6 | 47.4 | 98.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.238 | 0.418 | 9.1 | 10.2 | 10.6 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 116 | 59.5 | 73 | 60.8 | 120 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7 | 6.98 | 6.49 | 6.13 | 4.9 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 278 | 279 | 325 | 333 | 465 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.64 | 31.9 | 18 | 27.2 | 36 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 91.7 | 98.8 | 164 | 177 | 203 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 186 | 180 | 161 | 157 | 262 |
| Total Liabilities & Shareholders' Equity | 278 | 279 | 325 | 333 | 465 |
| Total Common Shares Outstanding |